-
Product Insights
Cap Blanc Solar PV Park
Cap Blanc Solar PV Park is a solar PV project located in Balearic Islands, Spain. The project is at the permitting stage. Empower your strategies with our Cap Blanc Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
NewNet Present Value Model: Capricor Therapeutics Inc’s CAP-1002
Empower your strategies with our Net Present Value Model: Capricor Therapeutics Inc's CAP-1002 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Anumigilimab in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anumigilimab in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anumigilimab in Rheumatoid Arthritis Drug Details: Anumigilimab (CSL324) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Silmitasertib in Basal Cell Carcinoma (Basal Cell Epithelioma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Silmitasertib in Basal Cell Carcinoma (Basal Cell Epithelioma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Silmitasertib in Basal Cell Carcinoma (Basal Cell...
-
Product Insights
NewNet Present Value Model: Nippon Shinyaku Co Ltd’s CAP-1002
Empower your strategies with our Net Present Value Model: Nippon Shinyaku Co Ltd's CAP-1002 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Reparixin in Community Acquired Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Reparixin in Community Acquired Pneumonia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Reparixin in Community Acquired Pneumonia Drug Details: Reparixin (Repertaxin) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Reparixin in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Reparixin in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Reparixin in Triple-Negative Breast Cancer (TNBC) Drug Details: Reparixin (Repertaxin)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Reparixin in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Reparixin in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Reparixin in Acute Respiratory Distress Syndrome Drug Details: Reparixin (Repertaxin)...
-
Product Insights
Cap Des Biches Gas Fired Combined Cycle Power Plant
Cap Des Biches Gas Fired Combined Cycle Power Plant is a thermal project located in Dakar, Senegal. The project is owned by Senegal National Electricity Agency; West African Energy SA and is developed by West African Energy SA. The project is currently under construction. Empower your strategies with our Cap Des Biches Gas Fired Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will...